PPD Licenses Informax s Genomax Bioinformatics Platform | GenomeWeb

NEW YORK, Feb 28 - PPD Discovery, the drug discovery division of Wilmington, NC-based PPD, has agreed to license Informax's Genomax bioinformatics system for its functional genomics research, PPD said Wednesday.

PPD's functional genomics research focuses on isolating gene inhibitors involved in cellular processes. The company will use the Genomax system to manage, analyze, and mine gene expression and function data.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.